Abstract
Background Years back, cancer was thought to be a problem limited to the developed countries. Cancer is now a disease with lots of burden, leading cause of death and disability in developing countries. Physical health is very important for the overall well-being of breast cancer survivors, since it is the visible part of the dimensions of overall health and well-being. Prior studies have examined factors leading to late detection, financial burden and experiences of caregivers of breast cancer patients in Ghana, however, none of the studies have explored how breast cancer may specifically impact the physical well-being and the quality of life of these women. This study therefore seeks to explore how breast cancer impact the physical well-being and the quality of life of these women.
Methodology The study site and setting was the Oncology directorate at Komfo Anokye Teaching Hospital where twelve respondents were recruited for the study. Breast care survivors were purposively sampled and interviewed (face-to-face) to explore how the BC has impacted on their physical wellbeing and their Quality of Life (QoL). Demographic data were obtained before the main interview. The interviews lasted between 30minutes to 45minutes. Data was analysed using thematic analysis of key information by using NVivo data management software.
Results Participants described their physical wellbeing according to the way they encountered the disease from the onset through to the treatment administration. Five sub-themes emerged, namely: Fatigue/bodily weakness: impaired functional ability: pain; distorted sleep; and fertility.
Conclusion Fatigue, impaired functional ability, pain, distorted sleep and fertility were consistent with constructs of the Quality of Life model. These physical symptoms negatively affected the total well-being of the BCSs.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The author(s) received no specific funding for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Separate ethical clearances were obtained from Kwame Nkrumah University of Science and Technology Committee on Human Rights Publication and Ethics (CHRPE) with ref no: CHRPE/AP/177/20 and the Institutional Review Board of Komfo Anokye Teaching Hospital (KATH-IRB) with ref no: KATH-IRB/AP/042/20 to permit the researcher to collect data for the study.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
Data collected this study are available at https://doi.org/10.6084/m9.figshare.24953595
